Your browser doesn't support javascript.
loading
Assessment of breast cancer chemotherapy dose reduction in an integrated healthcare delivery system.
Kantor, Elizabeth D; O'Connell, Kelli; Ergas, Isaac J; Valice, Emily; Roh, Janise M; Bhimani, Jenna; Heon, Narre; Griggs, Jennifer J; Lee, Jean; Bowles, Erin Ja; Rivera, Donna R; Kolevska, Tatjana; Bandera, Elisa V; Kushi, Lawrence H.
Affiliation
  • Kantor ED; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 633 3rd Ave, 3rd Floor, New York, NY, 10017, USA. kantore@mskcc.org.
  • O'Connell K; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA. kantore@mskcc.org.
  • Ergas IJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 633 3rd Ave, 3rd Floor, New York, NY, 10017, USA.
  • Valice E; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Roh JM; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Bhimani J; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Heon N; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 633 3rd Ave, 3rd Floor, New York, NY, 10017, USA.
  • Griggs JJ; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 633 3rd Ave, 3rd Floor, New York, NY, 10017, USA.
  • Lee J; Office of Faculty Professional Development, Diversity & Inclusion, Columbia University Irving Medical Center, New York, NY, USA.
  • Bowles EJ; Department of Medicine (Hematology/Oncology) and Health Management and Policy, Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, MI, USA.
  • Rivera DR; Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
  • Kolevska T; Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington, Seattle, WA, USA.
  • Bandera EV; Surveillance Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA.
  • Kushi LH; Kaiser Permanente Vallejo Medical Center, Kaiser Permanente Northern California, Vallejo, CA, USA.
Breast Cancer Res Treat ; 203(3): 565-574, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37923962
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Beta-Alanine / Delivery of Health Care, Integrated / Fumarates Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2024 Document type: Article Affiliation country: United States Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Beta-Alanine / Delivery of Health Care, Integrated / Fumarates Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2024 Document type: Article Affiliation country: United States Country of publication: Netherlands